Social Media Ideas for Biopx

Cytomos’ AuraCyt Digital Predictive Cell Analytics Platform Showcased at BIO Conference

Cytomos says its benchtop cell analytics intelligence system combines the compact Celledonia analyzer with the sensors of the AuraCyt modules to transform complex cellular data int...

BIFOX ENTERS INTO AGREEMENTS TO ACQUIRE THE 550 MILLION TONNE[1] BAYOVAR 9 PHOSPHATE ROCK PROJECT IN PERU POSITIONING BI...

SYDNEY, June 15, 2026 /PRNewswire/ -- Bifox Limited ("Bifox") is pleased to advise it has entered into two agreements with Fossal S.A.A ("Fossal"), to purchase all of the shares of...

The State of Biologics Testing Report 2026

This report is intended to inform discussion and decision making, not to prescribe solutions. Produced in collaboration with GEN, it reflects the collective voice of an industry ad...

Revolutionary 3D Motion Capture Imaging Lands in U.S.

Imaging that doesn’t force patients to lie still? Now, ORA Orthopedics is changing that equation in a big way.

GlobalMed and OXOS Partner to Bring X-ray to the Point of Need - Exclusive U.S. Federal Deployment Rights Secured

GlobalMed, a global leader in digital health solutions, today announced a strategic partnership with OXOS Medical, Inc. and their mission to bring X-ray to the point of need to del...

BioTNS selected as host of gov't's ultra-precision digital PCR project

BioTNS, a Korean molecular diagnostics company, was selected as the host organization to spearhead a 30 billion won ($19.53 million) government program to set up technical standard...

OSE Immunotherapeutics SA (ORPOF) Discussion of Tedopi Immunotherapy Pipeline and Clinical Progress Across Oncology Indi...

Boster Bio Expands Access to Validated CD68 Antibody Marker for IHC and Translational Research

<![CDATA[Solving Data Problems with Casual Human Biology: Q&A with Dr. Brent Richards]]>

A New Approach to Supporting Quality of Biologics

The United States Pharmacopeia (USP) is proposing a new approach for its work to support the quality and availability of selected biologic medicines. Building on decades of experie...

Olympus pushes deeper into oncology with $270M BioProtect deal

Olympus is pushing deeper into prostate cancer care with the acquisition of BioProtect, an Israeli company whose biodegradable balloon spacer has been used in more than 11,000 proc...

Study Finds Lung Biopsy Cryoprobe Significantly Improves Diagnostic Accuracy Compared to Standard Forceps

A groundbreaking clinical trial has reshaped the landscape of interventional pulmonology by demonstrating a remarkable improvement in diagnostic accuracy when employing cryobiopsy...

Oxford Biomedica plc (OXBDF) Analyst/Investor Day - Slideshow

ImmunityBio: Could Be One Approval Away From A Multi-Billion Dollar Breakout

BioVenic Strengthens Veterinary Organoid Culture System Development with Animal-Free Recombinant Proteins

BioVenic announced enhanced support for veterinary organoid culture system development, combining animal-free recombinant protein-informed medium optimization, 3D organoid model es...

Local PBMC Isolation Enables Four-Hour Processing in San Diego

OrganaBio’s new San Diego cell processing site expands access to fast PBMC isolation and cryopreservation, thus improving quality, consistency, and supply chain surety for these vi...

bioAffinity Technologies, Inc. (BIAF) Discusses Noninvasive Testing and Risk Stratification for Indeterminate Lung Nodul...

Portable CRISPR Assay Advances Mpox Detection 2025

In the wake of the 2025 Mpox outbreak that extensively affected Sierra Leone, a groundbreaking scientific advancement has been reported, spearheading diagnostic methodologies and e...

BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Bi...

BioRestorative Therapies, Inc. today announced the successful completion of manufacturing for its BRTX-100 Phase 2 clinical trial.

From Discovery to Development in Emerging Modalities

ProBio is building flexible platforms for multispecific antibodies, ADCs, and other advanced therapeutic approaches. The post From Discovery to Development in Emerging Modalities a...

Reverse Engineering BNIP3 Reveals Mitochondrial Protector

In an extraordinary leap forward for mitochondrial biology and peptide therapeutics, a research team led by Hendgen-Cotta and colleagues has unveiled a groundbreaking discovery tha...

BioAge Labs, Inc. (BIOA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript